Anti-obesity medication

Intellectia 5 candidates

The thematic keyword "U.S.-listed anti-obesity medication stocks and any company related to anti-obesity medication" focuses on the pharmaceutical sector's efforts to combat the global obesity epidemic.

AI Screener Cover Image: Anti-obesity medication

Name

Price

%Chg

Market Cap

LLY

Eli Lilly and Co

$1056.81

+2.85%

971.39B

NVO

Novo Nordisk A/S

$50.36

+0.36%

222.83B

JNJ

Johnson & Johnson

$213.91

+1.10%

509.76B

MRK

Merck & Co Inc

$99.31

-0.99%

248.95B

ABBV

AbbVie Inc

$226.51

+1.43%

394.69B

This list is generated based on data from one or more third party data providers. It is provided for informational purposes only by Intellectia.AI, and is not investment advice or a recommendation. Intellectia does not make any warranty or guarantee relating to the accuracy, timeliness or completeness of any third-party information, and the provision of this information does not constitute a recommendation.

Popular Themes

Home Improvement

19 candidates

+0.16%

Advertising Technologies

Israeli-Palestinian Conflict

15 candidates

-0.06%

Frequently Asked Questions

What is the Anti-obesity medication stock list?

Which stocks are included in the theme of Anti-obesity medication?

The list includes top performers like Eli Lilly and Co (LLY.N), Novo Nordisk A/S (NVO.N), Johnson & Johnson (JNJ.N), Merck & Co Inc (MRK.N), among others. These stocks are representative examples from Anti-obesity medication stock list.